Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Absorption Systems Sets Up GLP Facility
Absorption Systems has introduced a renovated surgical suite for preclinical medical device testing at the company’s facility in San Diego, CA. The company’s AAALAC accredited, GLP-compliant facility is
Absorption Systems has introduced a renovated surgical suite for preclinical medical device testing at the company’s facility in San Diego, CA. The company’s AAALAC accredited, GLP-compliant facility is
Stentys has reported the first patient enrollment in the Apposition II clinical study, a randomised trial comparing the Stentys self-expanding stent with a balloon-expandable stent in AMI patients.
Oxygen Biotherapeutics (Oxygen) has reported the enrollment of first patient in the Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte emulsion in traumatic brain
Elan Drug Technologies, a business unit of Elan, has reported that Janssen-Cilag has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency for Paliperidone Palmitate, aimed
The FDA has approved Santarus’s New Drug Application (NDA) for immediate-release Omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40mg and 20mg dosage strengths of Omeprazole. Santarus had submitted the
Taro Pharmaceutical (Taro) has been granted an Investigational New Drug (IND) exemption by the FDA, to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid). T2000 is one of a
Bristol-Myers Squibb and Pfizer are planning to submit an application for regulatory approval of Apixaban in Europe, for the prevention of venous thromboembolism (VTE) after orthopedic surgery, in
Radient Pharmaceuticals has received approval from the Korean FDA (KFDA) for Onko-Sure in-vitro diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea. The company has
Merck & Co has received FDA approval for Zegerid OTC (omeprazole 20mg/sodium bicarbonate 1100mg capsules), for over-the-counter treatment of frequent heartburn. Zegerid OTC will be marketed over-the-counter by
Milestone Scientific (Milestone) has entered into a joint venture with China National Medicines (d/b/a Sinopharm) and Yichang Humanwell Pharmaceutical (Yichang Humanwell), to develop orthopedic and epidural drug delivery